Using serum placenta growth factor could improve the sensitivity of colorectal cancer screening in fecal occult blood negative population: A multicenter with independent cohort validation study-Reference-Cited by-同舟云学术

Using serum placenta growth factor could improve the sensitivity of colorectal cancer screening in fecal occult blood negative population: A multicenter with independent cohort validation study

Published:2019-05-07 Issue:7 Volume:8 Page:3583-3591
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Wei Shu‐Chen¹^ORCID,Tsao Po‐Nien²³,Wang Yu‐Ting⁴,Lin Been‐Ren⁵,Wu Deng‐Chyang⁶,Tsai Wen‐Sy⁷⁸,Chen Jinn‐Shiun⁷,Wong Jau‐Min¹

Affiliation:

1. Department of Internal Medicine National Taiwan University Hospital and College of Medicine Taipei Taiwan

2. Department of Pediatrics National Taiwan University Children’s Hospital and National Taiwan University Taipei Taiwan

3. The Research Center for Developmental Biology and Regenerative Medicine National Taiwan University Taipei Taiwan

4. Department of Medical Research National Taiwan University Hospital Taipei Taiwan

5. Department of Surgery National Taiwan University Hospital and College of Medicine Taipei Taiwan

6. Division of Gastroenterology, Department of Internal Medicine Kaohsiung Medical University Hospital Kaohsiung Taiwan

7. Division of Colon and Rectal Surgery Chang Gung Memorial Hospital Linkou Taiwan

8. School of Medicine Chang Gung University Taoyuan Taiwan

Funder

Ministry of Health and Wealth of Taiwan

Foundation of Liver Disease Prevention and Treatment, Taiwan

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2216

Reference39 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Reduced incidence and mortality from colorectal cancer with flexible-sigmoidoscopy screening: A meta-analysis

3. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies

4. The Impact of Screening on Colorectal Cancer Mortality and Incidence: Has It Really Made a Difference?

5. Screening for Colorectal Cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between molecular prognostic factors and bevacizumab therapeutic resistance in patients with metastatic colorectal cancer; the AVAMET study;Journal of Mind and Medical Sciences;2024-04-30

2. Overexpression of CD44v8-10 in Colon Polyps—A Possible Key to Early Diagnosis;Pathology and Oncology Research;2021-03-30

3. Impact of Prior Bevacizumab Treatment on VEGF-A and PlGF Levels and Outcome Following Second-Line Aflibercept Treatment: Biomarker Post Hoc Analysis of the VELOUR Trial;Clinical Cancer Research;2019-11-14